Biondo Focus Fund Investor Class (BFONX)

13.10
Net Asset Value
+0.69%
1 Day
-7.75%
Year-to-Date
Overall Morningstar Rating
Large growth
Style or Category
No Load
Sales Expenses
2.62%
Expense Ratio
High
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund invests primarily in a combination of long and short positions in (1) common stock of U.S. companies of any capitalization; (2) American depositary receipts ("ADRs") representing common stock of foreign companies; (3) investment grade fixed income securities; (4) exchange-traded funds and (5) options on common stock, ADRs and ETFs. It may also employ leverage including bank borrowing of up to 33% of the fund's assets (defined as net assets plus borrowing for investment purposes). The fund is non-diversified.

Performance

1 month+4.88% 3 years+3.49%
3 months+2.42% 5 years+5.55%
1 year-14.77% Since inception+3.86%
Data through --

Peer Comparisonvs. Large growth

 BFONXCategory
Performance 5-yr return+5.55%+9.98%
Expense ratio2.62%1.17%
Risk 5 year sharpe ratio0.280.84
Net assets$19.6M$2.8B
Average market cap$50.5B$88.4B
Average P/E24.127.9
Portfolio turnover55%55%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyBiondo Investment Advisor
Fund manager & tenureJoseph Biondo / 6 Years
Minimal initial investment$1,000.00
Minimum IRA investment$500.00

Holdings

U.S. stock109.00%
International stock0.00%
Fixed income0.00%
Cash0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 32.03%
Financial service 21.84%
Hardware 16.61%
Consumer goods 15.35%
Industrial materials 7.19%
Top 10 Holdings
Portfolio weighting
-- 15.68%
FB Facebook12.43%
ISRG Intuitive Surgical11.81%
MA MasterCard11.15%
CELG Celgene8.59%
GILD Gilead Sciences7.09%
AAPL Apple5.80%
CLB Core Laboratories NV5.64%
-- 5.59%
PCRX Pacira Pharmaceuticals Inc4.92%

Partner Offers

NextAdvisor